Long-term oxygen therapy: are we prescribing appropriately?

Area of Science:

• Pulmonary Medicine
• Respiratory Care

Background:

• Long-term oxygen therapy (LTOT) is a proven survival-improving treatment for chronic obstructive pulmonary disease (COPD) patients experiencing chronic respiratory failure.
• LTOT also offers benefits such as reduced hospitalizations, enhanced exercise capacity, and improved quality of life.

Purpose of the Study:

• To review the established criteria and guidelines for prescribing LTOT in COPD patients.
• To discuss critical considerations for optimizing LTOT efficacy, including dosage, compliance, and application in specific patient subgroups.

Main Methods:

• Review of current LTOT guidelines and clinical evidence.
• Analysis of diagnostic methods for assessing hypoxemia at rest, during exercise, and during sleep.
• Discussion of potential challenges and areas for further research in LTOT.

Main Results:

• Standard LTOT is indicated for stable COPD patients with PaO2 < 60 mmHg on optimal medical therapy.
• Guidelines recommend LTOT for at least 18 hours daily, with 24 hours potentially being more beneficial.
• Effective LTOT requires correction of hypoxemia, verified by blood gas analysis during rest, exercise, and sleep to prevent complications like hypoventilation.

Conclusions:

• LTOT is crucial for improving survival and quality of life in severe COPD.
• Accurate assessment of oxygenation status across different conditions (rest, exercise, sleep) is vital for effective LTOT.
• Further research is needed on LTOT use in moderate hypoxemia, exercise/sleep desaturation, optimal dosing, compliance, and non-COPD conditions.